Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Rejection After Auxiliary Partial Orthotopic Liver Transplantation: An Exploratory Comparison by Native-Liver Cirrhosis Status

A legfontosabb adatok

Ki végzi
Zhi-Jun Zhu
Hol
Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
44 fő vett részt
Kezdés
2025. dec. 1.
Befejezés
2026. jún. 30.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A regiszteradat frissítve
2026. november 2.

Ki vehet részt

Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 8 feltétel megnézéseKevesebb

Ki vehet részt

  • Recipients who underwent auxiliary partial orthotopic liver transplantation (APOLT) at Beijing Friendship Hospital, Capital Medical University, between 2014 and 2025
  • Patients with a confirmed underlying liver disease
  • Patients without a history of previous solid-organ transplantation
  • Patients with available histopathological examination of native-liver tissue obtained during the initial APOLT procedure, allowing classification of native-liver cirrhosis status
  • Patients with sufficient clinical records and follow-up information to establish baseline characteristics, operative variables, and the occurrence and timing of the primary outcome or the applicable censoring time

Ki nem vehet részt

  • Patients who underwent APOLT for acute or subacute liver failure
  • Patients with idiopathic portal hypertension without histopathological evidence of cirrhosis
  • Patients with insufficient clinical or follow-up data to determine eligibility, classify native-liver cirrhosis status, or assess the primary outcome

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This retrospective single-center cohort study aims to investigate the association between native-liver cirrhosis status and post-transplant outcomes in recipients undergoing auxiliary partial orthotopic liver transplantation (APOLT). A total of 44 recipients who underwent APOLT between 2014 and 2025 will be included and classified into non-cirrhotic and cirrhotic groups according to the histopathological findings of the retained native liver. The study will compare biopsy-proven rejection, including first and recurrent rejection episodes, postoperative complications, overall survival, and graft survival between the two groups. The findings may help improve understanding of the relationship between native-liver cirrhosis status and post-transplant outcomes and provide evidence for future clinical research and individualized post-transplant management.

A vizsgálat 2 csoportja

  • Non-cirrhotic native liver

    Recipients undergoing APOLT whose retained native liver showed no histopathological evidence of cirrhosis. A total of 11 recipients were included in this cohort. Outcomes were assessed retrospectively based on medical records, including biopsy-proven rejection, postoperative complications, overall survival, and graft survival.

  • Cirrhotic native liver

    Recipients undergoing APOLT whose retained native liver showed histopathological evidence of cirrhosis. A total of 33 recipients were included in this cohort. Outcomes were assessed retrospectively based on medical records, including biopsy-proven rejection, postoperative complications, overall survival, and graft survival.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. november 2.